Pfizer reported strong financial performance in the 4th quarter of 2011, meeting or exceeding their annual financial guidance. Their revenue was boosted by their blockbuster drug Viagra and efforts to slim down and restructure the company. For 2011, Pfizer returned over $15 billion to shareholders through dividends and share repurchases, demonstrating solid financial results.

1. PFIZER
Financial analysis (4th quarter 2011)

2. OVERVIEW
 About Pfizer
 Financial performance 4th quarter
 Financial guidance 2011 (annual)
 Conclusion

3. ABOUT PFIZER
 American multinational pharmaceutical corporation
 Little blue pill
 Slimming down and restructuring

4. INCOME STATEMENT HIGHLIGHTS

5. QUARTERLY ADJUSTED INCOME

6. BUSINESS REVENUES

7. FINANCIAL GUIDANCE 2011 (ANNUAL
FIGURES)

8. TO CONCLUDE
 Finished 2011 with a solid Q4; overall financial
performance for the year was strong.
 Met or exceeded every aspect of their 2011
financial guidance.
 Returned over $15 billion to shareholders through
dividends and share repurchases during 2011.

9. THANK YOU FOR YOUR ATTENTION
Source:
www.pfizer.com